
MOLECULAR GENETIC CHARACTERIZATION OF
b-THALASSEMIA AND SICKLE CELL SYNDROME
IN THE ALBANIAN POPULATION Babameto-Laku A1,*, Mitre A2, Berisha S2, Mokini V1, Roko D1 *Corresponding Author: Anila Babameto-Laku, University Hospital Center “Mother Teresa”, Faculty of Medicine,
Service of Medical Genetics, Rruga Dibres, 307, Tirana, Albania; Tel.: +68-20-94-170; Fax: +355-4-227-2782;
E-mail: laku62@yahoo.com page: 45
|
INTRODUCTION
b-Thalassemia (b-thal) (OMIM 141900), the
most common hereditary anemia in the Mediterranean
region, results from over 200 causative mutations in
the b-globin gene (HBB) [1]. These are responsible either
for reduction (b+) or complete absence (b0) of the
b chain and lead to a mild-to-severe hemolytic anemia
[2]. Despite the molecular heterogeneity, the prevalent
molecular defects are limited in number in each population
that is at risk. Such mutations can be detected by
a number of polymerase chain reaction (PCR)-based
procedures. The most used methods are reverse dotblot
analysis or primer-specific amplification, with
a set of probes complementary to the most common
mutations in a particular population, and denaturing
high performance liquid chromatography (HPLC) [3].
Should these methods fail to detect a mutation, sequence
analysis can detect any mutation in the HBB
coding region.
Like most other neighboring countries in the region,
Albania is affected by thalassemia and hemoglobin
(Hb) disorders. It is estimated that the overall carrier
frequency of b-thal and sickle cell anemia is about
7-8%. Most patients are located in the provinces along
the Adriatic and Ionian coasts where malaria used to
be endemic [4]. The aim of this study was to determine
the different b-thal alleles that are present in the Albanian
population using a highly sensitive, cost-effective and suitable method for the high throughput screening
of a large number of samples.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|